Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion

Transplantation

Volumn 66, Issue 8, 1998, Pages 982-990

  Garcia Criado, F J ^a   Eleno, N ^a   Santos Benito, F ^a   Valdunciel, J J ^a   Reverte, M ^a   Lozano Sanchez F S ^a   Ludena M D ^a   Gomez Alonso, A ^a   Lopez Novoa J M ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRALAZINE; MOLSIDOMINE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNE RESPONSE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; CYTOKINES; FREE RADICAL SCAVENGERS; ISCHEMIA; KIDNEY; KIDNEY FUNCTION TESTS; MALE; NEPHRITIS; NITRIC OXIDE; PEROXIDASE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RENAL CIRCULATION; REPERFUSION INJURY; SUPEROXIDES; SURVIVAL ANALYSIS;

EID: 0032573048     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810270-00003     Document Type: Article

References (38)

1. Furlong B, Henderson AH, Lewis MJ, et al. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987; 90: 687.
2. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181.
3. Bath PMW, Hassall DG, Gladwin AM, Palmer RMJ, Martin JF. Nitric oxide and prostacyclin: divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb 1991; 11: 254.
4. Cooke JP, Tsao PS. Cytoprotective effects of nitric oxide. Circulation 1993; 88: 2451.
5. Radomski MW, Palmer RMJ, Moncada S. The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639.
6. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651.
7. Mullane KM. Myocardial ischemia-reperfusion injury. Role of neutrophils and neutrophil derived mediators. In: Marone G, ed. Current concepts in immunology: clinical immunology, Vol. 1. Human inflammatory disease. BC Decker, Burlington, ON, Canada: 1988: 143.
8. Johnson G III, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991; 19: 244.
9. Linas S, Whittenburg D, Repine JE. Nitric oxide prevents neutrophil-mediated acute renal failure. Am J Physiol 1997; 272: F48.
10. Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 1994; 91: 1691.
11. Cristol JP, Thiemermann C, Mitchell JA, et al. Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites. Br J Pharmacol 1993; 109: 188.
12. Myers SI, Hernandez R, Castaneda A. Possible role for oxygen free radicals in the regulation of renal nitric oxide synthesis and blood flow. Am J Surg 1995; 169: 604.
13. Dagher F, Pollina RM, Rogers DM, Gennaro M, Ascer E. The value and limitations of L-arginine infusion on glomerular and tubular function in the ischemic/reperfused kidney. J Vasc Surg 1995; 21: 453.
14. Yukimura T, Yamashita Y, Miura K, Okamura M, Yamanaka S, Yamamoto K. Renal effects of the nitric oxide synthase inhibitor, L-NG-nitroarginine, in dogs. Am J Hypertens 1992; 5: 484.
15. Rivas-Cabañero L, Montero A, Löpez-Novoa JM. Increased glomerular nitric oxide synthesis in gentamicin-induced renal failure. Eur J Pharmacol 1994; 270: 119.
16. Rivas Cabañero L, Rodríguez-López A, Martínez-Salgado C, Saura M, Lamas S, López-Novoa JM. Gentamicin treatment increases mesangial cell nitric oxide production. Exp Nephrol 1997; 5: 23.
17. López-Farré A, Gómez-Garré D, Bernabeu F, López-Novoa JM. A role for endothelin in the maintenance of post ischemic renal failure in the rat. J Physiol (London) 1991; 444: 513.
18. Pfeffer JM, Pfeffer MA, Frohlich ED. Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 1971; 78: 957.
19. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14: 157.
20. Misra HP, Fridovich Y. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170.
21. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121.
22. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte gluthatione peroxidase. J Lab Clin Med 1967; 70: 158.
23. Forman HJ, Boveris A. Superoxide radical and hydrogen peroxide in mitochondria. In: Prior WA, ed. Free radicals in biology. New York: Academic Press, 1982: 65.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantites of proteins utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248.
25. Elsner D, Muntze A. Inhibition of synthesis of endothelium-derived nitric oxide in dogs. Am J Hypertens 1992; 5: 288.
26. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protection actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in drugs. Circulation 1993; 88: 2337.
27. Weyrich AS, Ma X, Leter AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992; 86: 279.
28. Johnson G III, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991; 19: 244.
29. Yao A, Gross GJ. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs: efficacy, time course, and role of the K-ATP channels. Circulation 1994; 89: 1229.
30. Yu L, Gengarro PE, Niederberger M, Burke TJ, Schrier TW. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 1994; 91: 1691.
31. 2 release from the hypothalamus. Proc Natl Acad Sci USA 1992; 89: 11543.
32. 2 production by vascular smooth muscle cells. Biochem Biophys Res Commun 1993; 194; 420.
33. Shimizu Y, Shaw S. Mucins in the mainstream. Nature 1993; 16: 630.
34. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651.
35. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454.
36. Hogg N, Darley-Usmar V, Wilson M, Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 1992; 281: 419.
37. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide production via a direct action on the NADPH-oxidase. J Clin Invest 1992 90: 1116.
38. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady H. Leucocytes, cell adhesion molecules and the ischemic acute renal failure. Kidney Int 1997; 51: 1463.